MicroRNA-200a Promotes Phagocytosis of Macrophages and Suppresses Cell Proliferation, Migration, and Invasion in Nasopharyngeal Carcinoma by Targeting CD47. 2020

Yunteng Zhao, and Xiaoxiao Yu, and Haocheng Tang, and Ri Han, and Xianwen Wang, and Jianqi Wang, and Ke Wang, and Gang Li
Department of Otolaryngology-Head and Neck Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, China.

Nasopharyngeal carcinoma (NPC) causes severe oncogenic lesions in the nasopharynx. CD47, a transmembrane integrin-associated protein, plays a key role in the ability of tumor cells to escape phagocytosis, working as an immune checkpoint in the immune response. Besides this role, CD47 has been reported to regulate cell proliferation and migration. The present study addresses the relationship between CD47 and microRNA-200a and examines their regulatory mechanisms in NPC. Bioinformatics analyses and dual-luciferase reporter assays were used to confirm the putative relationship between miR-200a and CD47, and their interaction was further detected using western blotting and RT-PCR. Further, results showed that miR-200a affect NPC cell proliferation, migration, and invasion by regulating CD47. A cell phagocytosis assay showed that miR-200a and a CD47 monoclonal antibody increased the sensitivity of NPC cells to macrophage phagocytosis by inhibiting the functions of CD47. Additionally, miR-200a expression was suppressed and CD47 expression increased in both clinical NPC tissues and cell lines. Taken together, these results show the miR-200a/CD47 combination as a potential therapeutic for treatment of NPC.

UI MeSH Term Description Entries
D008264 Macrophages The relatively long-lived phagocytic cell of mammalian tissues that are derived from blood MONOCYTES. Main types are PERITONEAL MACROPHAGES; ALVEOLAR MACROPHAGES; HISTIOCYTES; KUPFFER CELLS of the liver; and OSTEOCLASTS. They may further differentiate within chronic inflammatory lesions to EPITHELIOID CELLS or may fuse to form FOREIGN BODY GIANT CELLS or LANGHANS GIANT CELLS. (from The Dictionary of Cell Biology, Lackie and Dow, 3rd ed.) Bone Marrow-Derived Macrophages,Monocyte-Derived Macrophages,Macrophage,Macrophages, Monocyte-Derived,Bone Marrow Derived Macrophages,Bone Marrow-Derived Macrophage,Macrophage, Bone Marrow-Derived,Macrophage, Monocyte-Derived,Macrophages, Bone Marrow-Derived,Macrophages, Monocyte Derived,Monocyte Derived Macrophages,Monocyte-Derived Macrophage
D009361 Neoplasm Invasiveness Ability of neoplasms to infiltrate and actively destroy surrounding tissue. Invasiveness, Neoplasm,Neoplasm Invasion,Invasion, Neoplasm
D010587 Phagocytosis The engulfing and degradation of microorganisms; other cells that are dead, dying, or pathogenic; and foreign particles by phagocytic cells (PHAGOCYTES). Phagocytoses
D002465 Cell Movement The movement of cells from one location to another. Distinguish from CYTOKINESIS which is the process of dividing the CYTOPLASM of a cell. Cell Migration,Locomotion, Cell,Migration, Cell,Motility, Cell,Movement, Cell,Cell Locomotion,Cell Motility,Cell Movements,Movements, Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077274 Nasopharyngeal Carcinoma A carcinoma that originates in the EPITHELIUM of the NASOPHARYNX and includes four subtypes: keratinizing squamous cell, non-keratinizing, basaloid squamous cell, and PAPILLARY ADENOCARCINOMA. It is most prevalent in Southeast Asian populations and is associated with EPSTEIN-BARR VIRUS INFECTIONS. Somatic mutations associated with this cancer have been identified in NPCR, BAP1, UBAP1, ERBB2, ERBB3, MLL2, PIK3CA, KRAS, NRAS, and ARID1A genes. Carcinoma, Nasopharyngeal,Carcinomas, Nasopharyngeal,Nasopharyngeal Carcinomas
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D049109 Cell Proliferation All of the processes involved in increasing CELL NUMBER including CELL DIVISION. Cell Growth in Number,Cellular Proliferation,Cell Multiplication,Cell Number Growth,Growth, Cell Number,Multiplication, Cell,Number Growth, Cell,Proliferation, Cell,Proliferation, Cellular
D051928 CD47 Antigen A ubiquitously expressed membrane glycoprotein. It interacts with a variety of INTEGRINS and mediates responses to EXTRACELLULAR MATRIX PROTEINS. Antigens, CD47,CD47 Antigens,IAP-50 Antigen,Integrin-Associated Protein p50,Thrombospondin-1 Receptor CD47,Antigen, CD47,Antigen, IAP-50,CD47, Thrombospondin-1 Receptor,IAP 50 Antigen,Integrin Associated Protein p50
D035683 MicroRNAs Small double-stranded, non-protein coding RNAs, 21-25 nucleotides in length generated from single-stranded microRNA gene transcripts by the same RIBONUCLEASE III, Dicer, that produces small interfering RNAs (RNA, SMALL INTERFERING). They become part of the RNA-INDUCED SILENCING COMPLEX and repress the translation (TRANSLATION, GENETIC) of target RNA by binding to homologous 3'UTR region as an imperfect match. The small temporal RNAs (stRNAs), let-7 and lin-4, from C. elegans, are the first 2 miRNAs discovered, and are from a class of miRNAs involved in developmental timing. RNA, Small Temporal,Small Temporal RNA,miRNA,stRNA,Micro RNA,MicroRNA,Primary MicroRNA,Primary miRNA,miRNAs,pre-miRNA,pri-miRNA,MicroRNA, Primary,RNA, Micro,Temporal RNA, Small,miRNA, Primary,pre miRNA,pri miRNA

Related Publications

Yunteng Zhao, and Xiaoxiao Yu, and Haocheng Tang, and Ri Han, and Xianwen Wang, and Jianqi Wang, and Ke Wang, and Gang Li
November 2019, Journal of biochemistry,
Yunteng Zhao, and Xiaoxiao Yu, and Haocheng Tang, and Ri Han, and Xianwen Wang, and Jianqi Wang, and Ke Wang, and Gang Li
January 2017, Oncology research,
Yunteng Zhao, and Xiaoxiao Yu, and Haocheng Tang, and Ri Han, and Xianwen Wang, and Jianqi Wang, and Ke Wang, and Gang Li
October 2016, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine,
Yunteng Zhao, and Xiaoxiao Yu, and Haocheng Tang, and Ri Han, and Xianwen Wang, and Jianqi Wang, and Ke Wang, and Gang Li
August 2018, Experimental and therapeutic medicine,
Yunteng Zhao, and Xiaoxiao Yu, and Haocheng Tang, and Ri Han, and Xianwen Wang, and Jianqi Wang, and Ke Wang, and Gang Li
July 2024, Experimental and therapeutic medicine,
Yunteng Zhao, and Xiaoxiao Yu, and Haocheng Tang, and Ri Han, and Xianwen Wang, and Jianqi Wang, and Ke Wang, and Gang Li
January 2022, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine,
Yunteng Zhao, and Xiaoxiao Yu, and Haocheng Tang, and Ri Han, and Xianwen Wang, and Jianqi Wang, and Ke Wang, and Gang Li
January 2020, Journal of Cancer,
Yunteng Zhao, and Xiaoxiao Yu, and Haocheng Tang, and Ri Han, and Xianwen Wang, and Jianqi Wang, and Ke Wang, and Gang Li
May 2020, Molecular medicine reports,
Yunteng Zhao, and Xiaoxiao Yu, and Haocheng Tang, and Ri Han, and Xianwen Wang, and Jianqi Wang, and Ke Wang, and Gang Li
January 2017, OncoTargets and therapy,
Yunteng Zhao, and Xiaoxiao Yu, and Haocheng Tang, and Ri Han, and Xianwen Wang, and Jianqi Wang, and Ke Wang, and Gang Li
January 2019, European review for medical and pharmacological sciences,
Copied contents to your clipboard!